Integration of adenovirus thymidine kinase suicide-gene therapy with surgery and radiation therapy for malignant glioma

Future Oncology

Volumn 8, Issue 1, 2012, Pages 17-20

  McBride, William H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADENOVIRUS VECTOR; THYMIDINE KINASE; VALACICLOVIR;

ADENOVIRUS; ARTICLE; CELL INFILTRATION; GLIOBLASTOMA; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; SUICIDE GENE THERAPY; SURVIVAL;

EID: 83655196955     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.11.126     Document Type: Article

References (17)

1. Chiocca EA, Aguilar LK, Bell SD et al. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. J. Clin. Oncol. 29(27), 3611-3619 (2011)
2. Vile RG, Nelson JA, Castleden S, Chong H, Hart IR. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res. 54(23), 6228-6234 (1994). (Pubitemid 24378658)
3. Kim JH, Kim SH, Brown SL, Freytag SO. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV Tk gene. Cancer Res. 54(23), 6053-6056 (1994). (Pubitemid 24378627)
4. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg. 81, 256-260 (1994). (Pubitemid 24238006)
5. Brust D, Feden J, Farnsworth J, Amir C, Broaddus WC, Valerie K. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion. Cancer GeneTher. 7(5), 778-788 (2000). (Pubitemid 30314062)
6. Germano IM, Fable J, Gultekin SH, Silvers A. Adenovirus/herpes simplex-thymidine kinase/ ganciclovir complex: preliminary results of a Phase 1 trial in patients with recurrent malignant gliomas. J. Neurooncol. 65(3), 279-289 (2003). (Pubitemid 37526820)
7. Immonen A, Vapalahti M, Tyynela K et al. AdvHSV Tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol. Ther. 10(5), 967-972 (2004). (Pubitemid 39419922)
8. Kramm CM, Korholz D, Rainov NG et al. Systemic activation of the immune system during ganciclovir treatment following intratumoral herpes simplex virus type 1 thymidine kinase gene transfer in an adolescent ependymoma patient. Neuropediatrics 33(1), 6-9 (2002). (Pubitemid 34273030)
9. Rainov NG, Kramm CM, Banning U et al. Immune response induced by retrovirus-mediated HSV Tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. Gene Ther. 7(21), 1853-1858 (2000).
10. Freytag SO, Movsas B, Aref I et al. Phase 1 trial of replication- competent adenovirus-mediated suicide-gene therapy combined with IMRT for prostate cancer. Mol. Ther. 15(5), 1016-1023 (2007). (Pubitemid 46621661)
11. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl Acad. Sci. USA 91(8), 3054-3057 (1994). (Pubitemid 24130173)
12. Floyd NS, Woo SY, Teh BS et al. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 58(3), 721-726 (2004). (Pubitemid 38221127)
13. Evers P, Lee PP, Demarco J et al. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer 10, 384 (2010).
14. Dewan MZ, Galloway AE, Kawashima N et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA 4 antibody. Clin. Cancer Res. 15(17), 5379-5388 (2009).
15. Rath P, Shi H, Maruniak JA, Litofsky NS, Maria BL, Kirk MD. Stem cells as vectors to deliver HSV/Tk gene therapy for malignant gliomas. Curr. Stem Cell Res. Ther. 4(1), 44-49 (2009).
16. McBride WH, Chiang CS, Olson JL et al. A sense of danger from radiation. Radiat. Res. 162(1), 1-19 (2004). (Pubitemid 39044714)
17. Schaue D, McBride WH. Links between innate immunity and normal tissue radiobiology. Radiat. Res. 173(4), 406-417 (2010).